Patients exhibit a substantial reduction, approximately 30%, in acetylcholinesterase activity in the brain, a factor strongly correlated with dementia, impaired cognitive function, gait disturbances, an increased propensity for falls, and sleep disorders. This evidence concerns the gene ACHE and dementia.